#4200 on the rich list of 14,644 insiders
Kevin McCulloch
See Remarks at Xeris Biopharma Holdings. Based in Chicago, Illinois.
$26.3M
in disclosed stock, −$586K (−2.18%) today
Market closed. Prices as of Nov 19, 4:04 PM ET
- Rank
- 4200th of 14,644
- Companies held
- 1
- Largest holding
- XERS, 100.0% of total
- Latest SEC filing
- Nov 5, 2026
What the $26.3M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Xeris Biopharma Holdings XERS Common Stock | Directly | 1,559,208 | $16.62 | $25.9M | 98.4% | Form 4, Nov 5, 2026 |
| Xeris Biopharma Holdings XERS Common Stock | Through Spouse | 25,000 | $16.62 | $416K | 1.6% | Form 4, Nov 5, 2026 |
Share counts are the amounts Kevin McCulloch reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Nov 5, 2026 | Sold | XERS | 25,000 | $12.49 | $312K | View |
| Nov 2, 2026 | Sold | XERS | 15,000 | $10.23 | $153K | View |
| Oct 1, 2026 | Sold | XERS | 15,000 | $9.41 | $141K | View |
| Sep 28, 2026 | Sold | XERS | 25,000 | $10.00 | $250K | View |
| Sep 1, 2026 | Sold | XERS | 15,000 | $8.49 | $127K | View |
| Aug 3, 2026 | Sold | XERS | 15,000 | $8.02 | $120K | View |
| Jul 1, 2026 | Sold | XERS | 90,000 | $8.03 | $723K | View |
| Jan 8, 2026 | Sold | XERS | 15,000 | $8.00 | $120K | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 4197 | Bryan C. Hanson Chief Executive Officer, Solventum. Eagan, MN | $26.3M |
| 4198 | Luc Seraphin President and CEO, Rambus. San Jose, CA | $26.3M |
| 4199 | William E. Jordan CHIEF LEGAL & POLICY OFFICER, EQT. Pittsburgh, PA | $26.3M |
| 4200 | Kevin McCulloch See Remarks, Xeris Biopharma Holdings. Chicago, IL | $26.3M |
| 4201 | Andrew D. Dickinson Chief Financial Officer, Gilead Sciences. Foster City, CA | $26.3M |
| 4202 | Randy L. Newman Director, Alerus Financial. Grand Forks, ND | $26.3M |
| 4203 | Chad R. Abraham CEO and Chairman, Piper Sandler Companies. Charlotte, NC | $26.3M |
Other Xeris Biopharma Holdings insiders
All XERS insiders- Paul R. Edick$63.5MSee Remarks. #2148 overall
- John Patrick Shannon Jr.$48.2MSee Remarks. #2611 overall
- Steven Pieper$22.4MSee Remarks. #4763 overall
- Beth Hecht$18.1MSee Remarks. #5610 overall
- Steven Prestrelski$12.0MChief Scientific Officer. #7674 overall
- John Johnson$11.8MDirector. #7243 overall
Questions
How much stock does Kevin McCulloch own?
Kevin McCulloch holds $26,329,537 in listed stock based on SEC filings and current prices, mostly Xeris Biopharma Holdings (XERS). That ranks 4200th on the Stock Rich List.
Is this Kevin McCulloch's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Kevin McCulloch last buy or sell stock?
The most recent open-market trade on file is a sale of 25,000 XERS shares on Nov 5, 2026 at $12.49.